Growth Opportunities in Viral Inactivation Market

According to the new market research report “Viral Inactivation Market by Product (Kits, Reagents, Systems, Services), Application (Stem Cell, Blood, Tissue, Cell & Gene Therapy), Method (Solvent Detergent, Pasteurization) & End User (Pharmaceutical and Biotechnology, CROs) — Global Forecast”, published by MarketsandMarkets™.

The Global Viral Inactivation market is expected to reach $ 320.5 million, will grow at a CAGR of 12.3%

Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=121427017

Browse and in-depth TOC on “Viral Inactivation Market”

85 — Tables

41 — Figures

130 — Pages

Major Drivers For Viral Inactivation Market:

· Rapid Growth in Pharmaceutical and Biotechnology Industries

· Increasing Number of New Drug Launches

· Strong R&D Investments in the Life Sciences Industry

· Increasing Government Support for Pharmaceutical and Biotechnology Industries

· High Incidence and Large Economic Burden of Chronic Diseases

The global market is segmented based on method, product, application, end user, and geography.

Based on end-user this market is categorized into pharmaceutical and biotechnology companies, contract research organizations, academic research institutes, and other end users. Other end user segment primarily includes cell banks, small cell culture laboratories and consultants, microbiology laboratories, immunology laboratories, molecular laboratories, animal facilities, toxicology laboratories, and media/sera manufacturers.

Request Research Sample Pages:https://www.marketsandmarkets.com/requestsampleNew.asp?id=121427017

Viral Inactivation Market By Application

• Blood & Blood Products
• Cellular & Gene Therapy Products
• Stem Cell Products
• Tissue & Tissue Products
• Vaccines and Therapeutics

The major players in the viral inactivation market include Clean Cells (France), Charles River Laboratories International, Inc. (U.S.), Danaher Corporation (U.S.), Merck KGaA (Germany), Parker Hannifin (U.S.), Rad Source Technologies (U.S.), Sartorius AG (Germany), SGS S.A. (Switzerland), Texcell, Inc. (France), Viral Inactivated Plasma Systems SA (Switzerland), and WuXi PharmaTech (Cayman) Inc. (China).

The geographic segments included in this report are Asia, Europe, North America, and the Rest of the World (RoW). The North America segment is further divided into Canada and the U.S. Asia segment is further divided into China, Japan, India, and Rest of Asia.

UV/Visible Spectroscopy Market | Business Overview, Products and Services, Key Insights, Recent Developments

The Global Market is expected to reach $ 1,163.2, growing at a CAGR of 4.3 % during the forecast period

According to the Latest Market research report Published by MarketsandMarkets the “UV/Visible Spectroscopy Market Size, Share, Demand and Growth Analysis, forecast”

However, the longevity of instruments and dearth of skilled professionals is likely to restrain the growth of the market to a certain extent during the forecast period.

Download PDF Brochure:

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=243898303

Expansions and product launches were the primary growth strategies adopted by major players to expand their product portfolio in the global UV/Visible Spectroscopy Market.

Growing opportunities in emerging nations, development of microvolume sampling-capable instruments, investments into the field of molecular diagnostics and growth of biobanking are likely to provide growth opportunities to the global UV/visible spectroscopy market. However, the dearth of skilled professionals and longevity of instruments is likely to restrain the growth of this market.

key players operating in the Global UV/Visible Spectroscopy Market;

The major players in the UV/visible spectroscopy market include Shimadzu Corporation (Japan), PerkinElmer Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Agilent Technologies Inc. (U.S.) and Hach Company (a subsidiary of Danaher Corporation) (U.S.), Jasco, Inc. (U.S.) Hamamatsu Photonics K.K. (Japan), Horiba, Ltd.(Japan), Hitachi High-Technologies Corp. (Japan) and Buck Scientific (U.S.) among others.

Major Drivers Impacting the UV/Visible Spectroscopy Market;

· Applications of UV/Visible Spectroscopy in Environmental Screening

· Growing Use of UV/Visible Spectroscopy in the Pharmaceuticals & Biotechnology Industry

· Technological Advancement

· Increasing Need for Food Analysis

Global UV/Visible Spectroscopy Market Segmentation:

The single-beam systems segment is expected to account for the largest share of the market, by instrument type. However, the array-based systems segment is expected to grow at the highest CAGR. The technological advancements in the array-based systems segment enable it to offer advantages such as improved sensitivity and faster data collection. These factors drive the growth of this segment.

Request Research Sample Pages:

https://www.marketsandmarkets.com/requestsampleNew.asp?id=243898303

UV/Visible Spectroscopy Market, by Application

• Academic Applications
• Physical Chemistry Studies
• Life Science Studies
• Environmental Sciences
• Industrial Applications
• Life Science R&D
• Production
• Quality Assurance/Quality Control (QA/QC)
• Environmental Testing

Research Insights on Rehabilitation Equipment Market Share, Size and Analysis Report

According to the new market research report “Rehabilitation Equipment Market by Type (Mobility (Wheelchair, Assist Device), Body Support (Lift, Sling), Exercise (Upper, Lower Body), Living Aids (Reading, Writing)), Application (Physiotherapy, OT), End User (Hospital, Clinic, Home Care) — Forecast”, published by MarketsandMarkets™.

Major Market Developments:

• In February 2017, Invacare upgraded the K series of its pioneering brand Küschall. The new active chair Küschall Champion SK is a sleek, smart, and lightweight folding wheelchair.
• In December 2016, Medline partnered with ViaQuest, Inc. (U.S.) to deliver ViaQuest Home Health and Hospice patient supplies across Indiana, Ohio, and Pennsylvania.
• In January 2017, Drive DeVilbiss Healthcare acquired Sidhil Group Limited (U.K.), a leading provider to homecare, acute care, and long-term care settings. This acquisition will expand Drive’s existing manufacturing capabilities in the U.K. while adding significant manufacturing expertise to the European platform.

Request for Sample Report @https://www.marketsandmarkets.com/requestsampleNew.asp?id=194775519

Home Care Settings

Home care is primarily targeted at patients recovering after a hospital stay or those who need additional support to avoid unnecessary hospitalization. The rehabilitation equipment used in home care settings include medical beds, patient lifts, power-operated vehicles like wheelchairs and scooters, and bathing and wound care equipment & accessories.

Major Drivers For Rehabilitation Equipment Market:

• Increasing Incidence of Disabilities
• Favorable Healthcare Reforms
• Rapid Growth in Geriatric Population
• Technological Advancements

Increasing incidence of disabilities and rapid growth in the geriatric population are the major drivers for the market.

The key causes of disabilities are non-communicable diseases and injuries such as sports injuries, trauma cases and various other injuries. Non-communicable diseases (NCDs) or chronic diseases are generally of long duration and slow progression. There are four major types of NCDs — cardiovascular disease (such as heart attacks and stroke), cancers, chronic respiratory disease (such as chronic obstructive pulmonary disease and asthma), and diabetes. NCDs are considered the leading cause for preventable disabilities such as paralysis and mental disorders among the patients.

Browse and in-depth TOC on “Rehabilitation Equipment Market”

154 — Tables

31 — Figures

162 — Pages

Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=194775519

The following are the major objectives of the study

• To define, describe, and forecast the Rehabilitation Equipment Market on the basis of type, application, and end user
• To provide detailed information regarding the major factors influencing growth of the market (drivers, restraints, opportunities, and challenges)
• To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the overall market
• To forecast the size of the market segments with respect to four main regions, namely, North America, Asia-Pacific, Europe, and the Rest of the World (RoW)

The Rehab Equipment Market is highly fragmented with the presence of several small and large players. Some of the prominent players in this market are Invacare Corporation (US), Medline Industries, Inc. (US), Dynatronics Corporation (US), Drive DeVilbiss Healthcare (US), Changzhou Qian Jing Rehabilitation Co., Ltd. (China)

The Rehabilitation Equipment Market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). Europe dominated the market, followed by North America. Factors such as supportive government initiatives for safe patient handling, growth in geriatric population, and the presence of a large number of players in Europe are driving the growth of the European market.

UV/Visible Spectroscopy Market Research Report 2019 By Key players and Growth Rate

The UV/visible spectroscopy market is expected to reach $ 1,163.2 million, at a CAGR of 4.3% during the forecast period.

The report “UV/Visible Spectroscopy Market by Instrument Type (Single-Beam, Dual-Beam), Application (Academic Application (Physical Chemistry Studies), Industrial Application (Life Sciences R&D, Environmental Testing) — Global Forecasts”, analyzes and studies the major market drivers, restraints/challenges, and opportunities.

Download PDF Brochure:

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=243898303

The global market is segmented based on instrument type, application, and region.

Based on instrument type, the market is segmented into single-beam systems, dual-beam systems, array-based systems, and handheld systems. In 2016, the single-beam systems segment is estimated to account for the major share of the UV/visible spectroscopy market. These instruments are routinely used analytical instruments in clinical examination, medicine, petrochemicals, biochemistry, biotechnology, quality control, and environmental protection as they are simple and economical.

UV/Visible Spectroscopy Market, by Application

• Academic Applications
• Physical Chemistry Studies
• Life Science Studies
• Environmental Sciences
• Industrial Applications
• Life Science R&D
• Production
• Quality Assurance/Quality Control (QA/QC)
• Environmental Testing

Major Growth Drivers for UV/Visible Spectroscopy Market:

· Applications of UV/Visible Spectroscopy in Environmental Screening

· Growing Use of UV/Visible Spectroscopy in the Pharmaceuticals & Biotechnology Industry

· Technological Advancement

· Increasing Need for Food Analysis

On the basis of region, the market is divided into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). North America is expected to account for the largest share of the UV/visible spectroscopy market. However, the Asia-Pacific market is slated to grow at the highest CAGR during the forecast period and serve as a revenue pocket for companies offering UV/visible spectroscopy systems and accessories. This is owing to the impetus provided by entry of key market players into this market, growing food safety and environmental pollution concerns and budding life science R&D sector in this region.

Request Research Sample Pages:

https://www.marketsandmarkets.com/requestsampleNew.asp?id=243898303

The major players in UV/visible spectroscopy market include Shimadzu Corporation (Japan), PerkinElmer Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Agilent Technologies Inc. (U.S.) and Hach Company (subsidiary of Danaher Corporation) (U.S.).

Growth Opportunities in Embolic Protection Device Market

The Research Report on Embolic Protection Device Market provides a detailed overview of growth in this market is mainly attributed to factors such as the rising incidence of cardiovascular and neurovascular diseases, growing funding and investments, the launch of technologically advanced embolic protection devices, and the rising demand for minimally invasive procedures.

The research report segments embolic protection device market based on type & material, application, indication, end users and region.

Download PDF (Embolic Protection):https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=158143803

Embolic Protection Devices Market Based on Type;

the distal filter devices segment is expected to grow at the highest CAGR during the forecast period. The high growth of this segment can primarily be attributed to the procedural benefits distal filter devices offer, such as ease of use, enhanced visibility, and crossing profile of the device.

Embolic Protection Devices Market Based on Material;

Nitinol accounted for the largest share of the market. This segment is also expected to grow at the highest rate in the market. The super-elastic material and braided nitinol design provide full wall apposition and this quality is expected to drive the growth of nitinol in the global market during the forecast period.

Global Embolic Protection Device Market, By Indication

• Percutaneous Coronary Intervention
• Carotid Artery Diseases Saphenous Vein Graft Disease
• Transcatheter Aortic Valve Replacement
• Other Indications

Request Research Sample Pages:https://www.marketsandmarkets.com/requestsampleNew.asp?id=158143803

Embolic Protection Devices Market Based on Application;

The embolic protection market is segmented into cardiovascular, neurovascular, and peripheral vascular diseases. According to this study, the neurovascular diseases segment is poised to grow at the fastest growth rate in the global market. With the increasing target patient population, the demand for embolic protection devices for the treatment of neurovascular diseases is expected to increase during the forecast period.

Prominent players in the embolic protection device market are Boston Scientific (US), Medtronic Ireland), Abbott (US), Cordis (A Cardinal Health Company) (US), Allium Medical Solutions (Israel), Contego Medical (US), W.L. Gore & Associates (US), Silk Road Medical (US), Claret Medical (US), and AngioSlide (Israel).

Needle-Free Injection System Market | Growth Drivers | Restraints | Opportunities and Trends

According to a new market research report “Needle-Free Injection System Market by Product (Fillable, Prefilled), by Technology (Jet, Spring, Laser, Vibration), Usability (Reusable, Disposable), Type of Medication (Liquid, Depot), Delivery Site (Intramuscular, Subcutaneous) — Forecasts ”, published by MarketsandMarkets

Growth in this market is mainly driven by the growing prevalence of the chronic disease, increasing the incidence of communicable disease due to needlestick injuries, rising demand for biosimilars and vaccination, advantages of drug delivery technology, increasing demand for self-injection devices.

Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=165815861

Based on the technology, the Needle-Free Injection System Market is divided into Jet-based needle-free injectors, spring-based needle-free injectors, laser-based needle-free injectors, and vibration-based needle-free injectors. The jet-based needle-free injector is expected to account for the largest market share in 2016, due to their advantages over the other injector systems.

Based on the Applications, the Needle-Free Injection System Market is segmented into vaccine delivery, insulin delivery, Oncology, pain management, and other applications; the vaccine delivery application segment is projected to be the fastest-growing segment during the forecast period in 2016. The growth of this market primarily attributed to factors such as the rising incidence of chronic diseases, technological advancement, and growing preference for self-medication.

Based on the end user, the Needle-Free Injection System Market is segmented into Hospitals and Clinics, home care settings, research laboratories, pharmaceutical and biotechnological companies and another end user. The hospitals and clinics segment are expected to grow at the highest rate in the forecast period. The growth in this segment can primarily be attributed to the advancement in the medication or drug delivery technology and rising geriatric population.

Request Research Sample Pages:https://www.marketsandmarkets.com/requestsampleNew.asp?id=165815861

Geographical Analysis:

The Needle-Free Injection System Market is dominated by North America, followed by Europe, Asia, and the Rest of the World. While North America is expected to dominate the market. Europe is expected to grow at the highest CAGR during the forecast period. The high growth in this market is attributed to the rising demand for biologics, growing prevalence of chronic diseases, technological advancements, mergers and acquisitions by major companies in the market, favorable reimbursement policies, increasing healthcare expenditure and regulatory approvals of new injection system are key factors driving the market growth in Europe

The Needle Free Injection System Market is a fragmented market, with several big and emerging players.Key market players include Antares Pharma, Inc. (U.S.), Endo International plc (U.S.), PharmaJet (U.S), Bioject Medical Technologies Inc. (U.S), Medical International Technology, Inc. (U.S), INJEX Pharma AG (Germany), National Medical Products Inc. (U.S.), Valeritas, Inc. (U.S.), European Pharma Group (Netherland), PenJet Corporation (U.S), Crossject SA (France).

HPV Testing and Pap Test Market: Worldwide Industry Analysis and New Market Opportunities Explored

The report “HPV Testing and Pap Test Market by Test Type (HPV Testing (Follow-Up, Co-Testing, Primary)), by Application (Pap Test (Cervical Cancer, Vaginal Cancer)), by End-User (Laboratories, Hospitals, Physicians’ Offices & Clinics) — Global Forecast”, published by MarketsandMarkets™

Cervical cancer is the second most common type of cancer in women, preceded by breast cancer. HPV, a sexually transmitted virus, has been clinically proven to be the primary cause of cervical cancer. HPV contributes to around 90% of all anal and cervical cancers and 70% of vaginal and vulvar cancers. Pap tests are the most preferred tests to detect cervical cancer. These tests include microscopic observation of specimens.

The HPV testing and Pap test Market is poised to reach USD 4,523.1 Million, at a CAGR of 6.6%

Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=214207371

The increasing number of cervical cancer cases and the growing aging population

Cervical cancer is considered to be the fourth most prevalent forms of cancer globally and is the most common cause of death among women (Source: Global Cancer Facts and figures). It has been estimated that 527,624 new cases of cervical cancer have emerged worldwide, while 265,653 women died due to cervical cancer in 2012. This figure is expected to reach to 609,270 new cases and 315,727 deaths by 2020. (Source: Globocan 2012). Approximately 26,000 new cancers attributable to HPV occur each year, 18,000 among females and 8,000 among males (Source: CDC). The growing number of cervical cancer cases results in the need for new, technically advanced, and less expensive screening programs. This, in turn is expected to drive the HPV testing and Pap test market in the coming years.

HPV Testing and Pap Test Market Drivers:

• The increasing number of cervical cancer cases and a growing aging population
• Increasing awareness of cervical cancer screening programs
• Government initiatives and funding.

Geographic Analysis:

• Detailed analysis of HPV testing and Pap test market in European countries such as the UK, Germany, France, Italy, Spain, and others

Geographically, the HPV testing and Pap test market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America is expected to grow at the highest CAGR in the forecast period. Increased government funding & grants and introduction of HPV primary tests are major factors fueling the growth of the HPV testing and Pap test market in North America.

Request Research Sample Pages:https://www.marketsandmarkets.com/requestsampleNew.asp?id=214207371

Key players in the HPV testing and Pap test market include Hologic Inc. (U.S.), Qiagen N.V. (Netherlands), F. Hoffmann-La Roche Ltd. (Switzerland), Quest Diagnostics (U.S.), OncoHealth Corporation (U.S.), and Becton, Dickinson and Company (U.S.). These players focus on inorganic and organic strategies such as product approvals & licenses, agreements, collaborations, and partnerships, expansions, acquisitions to sustain their growth in the HPV testing and Pap test market.